ETS vs NBIX · rev $726.8K vs P/E 45, rev $2.36B
Elite Express Holding Inc. Class A Common Stock (ETS) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Elite Express Holding Inc. Class A Common Stock (ETS) is a trucking company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ETS revenue for 2026-05-31 was $726.8K. Net income was -$2.5M. Revenue was down 9.7% from 2026-02-28 to 2026-05-31. ETS currently screens at market cap $9.8M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
ETS currently screens at market cap $9.8M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the ETS and NBIX stock pages for the full models.
Not investment advice.